Table 1.
Clinical information of patients
| Characteristics | Healthy donor (n = 25) | T-ALL patient (n = 39) | T-NHL patients (n = 4) | Patient with suspected abnormal hyperplasia of T-cell lymphoma (n = 5) | |||||
|---|---|---|---|---|---|---|---|---|---|
| Pro-T-ALL patient (n = 5) | Pre-T-ALL patient (n = 21) | Cortical T-ALL patient (n = 10) | Medullary T-ALL patient (n = 3) | PTCL patient (n = 1) | AITL patient (n = 2) | Patient with unclassified CD4 + T-cell lymphoma (n = 1) | |||
| Male | 15 | 29 | 3 | 2 | |||||
| Female | 10 | 10 | 1 | 3 | |||||
| Age range | 16–53 | 1–69 | 8–60 | 2–69 | |||||
| Median age | 37 | 16 | 33 | 28 | |||||
T-ALL T lineage acute lymphocytic leukemia; Pro-T-ALL early precursor T lineage acute lymphocytic leukemia; Pre-T-ALL precursor T lineage acute lymphocytic leukemia; PTCL Peripheral T-cell lymphomas; AITL angioimmunoblastic T-cell lymphoma; T-NHL T-cell Non-Hodgkin's lymphomas